ATE553755T1 - Stärke enthaltende beschichtungszusammensetzung - Google Patents

Stärke enthaltende beschichtungszusammensetzung

Info

Publication number
ATE553755T1
ATE553755T1 AT07789340T AT07789340T ATE553755T1 AT E553755 T1 ATE553755 T1 AT E553755T1 AT 07789340 T AT07789340 T AT 07789340T AT 07789340 T AT07789340 T AT 07789340T AT E553755 T1 ATE553755 T1 AT E553755T1
Authority
AT
Austria
Prior art keywords
coating composition
containing coating
starch containing
starch
formulations
Prior art date
Application number
AT07789340T
Other languages
German (de)
English (en)
Inventor
Gisela Fridrun Podczeck
Ana Cristina Teixeira De Almeida Freire
Original Assignee
Univ Sunderland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0614933A external-priority patent/GB0614933D0/en
Priority claimed from GB0617215A external-priority patent/GB0617215D0/en
Application filed by Univ Sunderland filed Critical Univ Sunderland
Application granted granted Critical
Publication of ATE553755T1 publication Critical patent/ATE553755T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
AT07789340T 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung ATE553755T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0614933A GB0614933D0 (en) 2006-07-27 2006-07-27 Composition
GB0617215A GB0617215D0 (en) 2006-09-01 2006-09-01 Composition
PCT/GB2007/050428 WO2008012573A1 (en) 2006-07-27 2007-07-20 Coating composition comprising starch

Publications (1)

Publication Number Publication Date
ATE553755T1 true ATE553755T1 (de) 2012-05-15

Family

ID=38698207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07789340T ATE553755T1 (de) 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung

Country Status (10)

Country Link
US (1) US20090285863A1 (https=)
EP (1) EP2046306B8 (https=)
JP (1) JP2009544684A (https=)
AT (1) ATE553755T1 (https=)
AU (1) AU2007279036A1 (https=)
BR (1) BRPI0715362A2 (https=)
CA (1) CA2658915A1 (https=)
MX (1) MX2009001085A (https=)
RU (1) RU2440104C2 (https=)
WO (1) WO2008012573A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009105409A2 (en) * 2008-02-19 2009-08-27 Mc Neil-Ppc, Inc. Dip coated compositions containing a starch having a high amylose content
ES2425762T3 (es) * 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
GB2567493B (en) * 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
GB201905940D0 (en) * 2019-04-29 2019-06-12 Intract Pharma Ltd 5-aminolevulinic acid for the local treatment of inflammatory bowel disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
JP2002511404A (ja) * 1998-03-27 2002-04-16 ヴァルション テクニッリネン トゥトキムスケスクス コーティングされたデンプンカプセル、およびこれらの製造方法
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
DE60041037D1 (de) * 2000-03-21 2009-01-22 St Microelectronics Srl Strang-programmierbarer nichtflüchtiger Speicher mit NOR-Architektur
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1981487B1 (en) * 2006-02-07 2014-06-25 Fmc Corporation Latex or pseudolatex compositions coatings and coating processes

Also Published As

Publication number Publication date
RU2440104C2 (ru) 2012-01-20
RU2009106260A (ru) 2010-09-10
EP2046306A1 (en) 2009-04-15
MX2009001085A (es) 2009-03-23
BRPI0715362A2 (pt) 2013-06-18
AU2007279036A1 (en) 2008-01-31
JP2009544684A (ja) 2009-12-17
WO2008012573A1 (en) 2008-01-31
US20090285863A1 (en) 2009-11-19
EP2046306B8 (en) 2012-06-27
CA2658915A1 (en) 2008-01-31
EP2046306B1 (en) 2012-04-18

Similar Documents

Publication Publication Date Title
CL2007002640A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
NO20082538L (no) Stabiliserte lantankarbonatsammensetninger
BRPI0718927A2 (pt) Método de imunização contra os quatro sorotipos da dengue.
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
BRPI0807012A2 (pt) Uso de inseticidas, método de reduzir ou evitar o efeito fitotóxico de fungicidas, e, agente.
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
EP2476461A3 (en) Formulations For Cancer Treatment
WO2008042231A3 (en) Compositions and methods for evaluating and treating heart failure
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2006135854A3 (en) Antiseptic compositions
NO20075111L (no) Farmasoytisk sammensetning
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
WO2009108932A3 (en) Selectin ligands useful in the diagnosis and treatment of cancer
WO2010078036A3 (en) Biocompatible polysaccharide-based hydrogels
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
ATE553755T1 (de) Stärke enthaltende beschichtungszusammensetzung
WO2006128041A3 (en) Compositions and methods for the treatment or prevention of chemoresistant neoplasia